Job ForCell Biologist Who Want Become A Cell Biologist, Pfizer Invites For Senior Scientist On Immune Cell Technology for working on Drugs development. Interested candidate can apply for this position through apply link. Scientific Talk never demand any charges so don’t pay fee for this jobs.
Virology Jobs In USA Apply
|Last Date For Apply||22 September 2022|
|Location||La Jolla, California|
|Job Type||Senior Scientist|
|Position Type||Full Time|
- PhD in Biology/Immunology/Biochemistry/Cell Biology, or related discipline.
- Cell biology expertise with immortalized and/or primary immune cell models
- Expertise with plate-based assays, FACS, ELISA, cytokine measures (MSD, Luminex), NanoBRET, and/or live-cell imaging
- Molecular biology experience such as cloning, lentivirus, stable transfection, or electroporation
- Experience with data analysis and presentation software.
- Excellent written and oral communication skills.
At Pfizer we deliver breakthroughs that change patients’ lives. Our Integrative Biotechnologies (IBT) team plays a vital role in this mission through the identification of therapeutic targets, leading drug discovery, and unraveling therapeutic mechanisms-of-action. In La Jolla, we are dedicated to the development of oncology agents that disrupt cancer biology or redirect the immune system against cancer cells.
As an IBT team member, you will enable biologic drug discovery (HTS), in vitro MoA, and CRISPR-based target ID through robustly reconstituting key immune processes in vitro. This includes a focus on myeloid biology, and encompasses assays with macrophages, T cells, and immortalized cell models as well as deployment of lentivirus-based cell engineering, CRISPR-KO and -Activation, and editing endogenous loci. Your responsibilities will include interfacing with project teams, developing research plans, contributing in-lab, managing CROs, and mentoring junior colleagues. You will work closely with individuals in drug design and immune-oncology groups to innovate and develop the next-generation immunotherapies.